{
  "pmcid": "9911325",
  "sha256": "50ff99bfa399c7f7674c630c509ee6ac5ec1ca1700605aa635fd2adda3d3108f",
  "timestamp_utc": "2025-11-09T16:23:02.956836+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 17.88571428571429,
    "reading_ease": 4.234285714285733,
    "word_count": 105
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 1,
        "evidence": "MIRTH is a novel catheter-based intramyocardial ventricular remodeling procedure."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 1,
        "evidence": "MIRTH causes a dose-dependent improvement in measures of left ventricular performance (increased contractility, increased ventricular mechanical efficiency, and reduced myocardial oxygen demand) in cardiomyopathic animals."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 2,
    "max_score": 25
  }
}